Patents by Inventor Keith Reemtsma

Keith Reemtsma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5227298
    Abstract: The subject invention provides a method of encapsulating viable tissue or cells within a double walled bead, the double-walled bean produced as a result of the method, as well as a method of pretreating the tissue or cells with an immunosuppressant such as UV-B irradiation prior to their encapsulation.
    Type: Grant
    Filed: August 17, 1990
    Date of Patent: July 13, 1993
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Collin J. Weber, Janet E. Norton, Keith Reemtsma
  • Patent number: 4946438
    Abstract: A patient's acceptance of transplanted organs and tissues may be enhanced by treating donor specific blood with a suitable dose of ultraviolet radiation for an appropriate period of time, transfusing the irradiated blood into the patient during a suitable pretransplantation time period and then transplanting the organ or tissue into the subject. Acceptance of transplanted organs and tissues can also be enhanced by treating the organs or tissues to be transplanted with a suitable dose of ultraviolet radiation for an appropriate period of time and then transplanting the organ or tissue. Suitably irradiated donor specific blood, organs and tissues are preferred for use in transplantation.
    Type: Grant
    Filed: June 12, 1989
    Date of Patent: August 7, 1990
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Keith Reemtsma, Mark A. Hardy, Henry T. Lau
  • Patent number: 4861704
    Abstract: A patient's acceptance of a transplanted organ or tissue from a donor may be enhanced by irradiating donor-specific blood with ultraviolet-B radiation at a dosage of less than 1000 J/M.sup.2 so as to render the blood capable of inducing donor-specific immunological unresponsiveness in the patient, transfusing the irradiated, donor-specific blood into the patient prior to transplanting the organ or tissue into the patient to enhance subsequent acceptance of the organ or tissue by the patient, and thereafter transplanting the organ or tissue into the subject.A patient's acceptance of transplanted organs and tissues can also be enhanced by removing the organ or tissue from the donor and irradiating the organ or tissue to be transplanted with ultraviolet-B radiation at a dosage of less than 1000 J/m.sup.2 so as to enhance acceptance of the transplanted organ or tissue and then transplanting the irradiated organ or tissue into patient.
    Type: Grant
    Filed: October 8, 1986
    Date of Patent: August 29, 1989
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Keith Reemtsma, Mark A. Hardy, Henry T. Lau
  • Patent number: 4581028
    Abstract: Infection-resistant materials, and methods of preparing same, suitable for use within the interior of a human or animal body in such forms as vascular grafts prostheses, or other implanted devices. The material is rendered infection-resistant by incorporating therein antimicrobial agents, such as metal salts of sulfonamides and other antimicrobials or antibacterials, such as piperacillin. In particular illustrative embodiments, silver sulfadiazine is complexed by novel techniques with natural or synthetic polymeric materials such as silk, polyester (e.g., Dacron), polyurethane, polytetrafluoroethylene, or silicone-based material, to provide long-term prevention of infections which may otherwise result during, or after, surgery or implantation of a device.
    Type: Grant
    Filed: April 30, 1984
    Date of Patent: April 8, 1986
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Charles L. Fox, Jr., Shanta Modak, Keith Reemtsma
  • Patent number: 4563485
    Abstract: Infection-resistant materials, and methods of preparing same, suitable for use within the interior of a human or animal body in such forms as vascular grafts prostheses, or other implanted devices. The material is rendered infection-resistant by incorporating therein antimicrobial agents, such as nalidixic acid derivatives or metal salts of nalidixic acid derivatives. In particular illustrative embodiments, silver norfloxacin and silver pefloxacin, are complexed with natural or synthetic polymeric materials such as silk, polyester (e.g., Dacron), polyurethane, polytetrafluoroethylene, or silicone-based material, to provide long-term prevention of infections which may otherwise result during or after surgery or implantation of a device.
    Type: Grant
    Filed: April 30, 1984
    Date of Patent: January 7, 1986
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Charles L. Fox, Jr., Shanta Modak, Keith Reemtsma